Sorafenib in patients with progressive malignant solitary fibrous tumors: a subgroup analysis from a phase II study of the French Sarcoma Group (GSF/GETO)

Author： Valentin T.   Fournier C.   Penel N.   Bompas E.   Chaigneau L.   Isambert N.   Chevreau C.  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.31, Iss.6, 2013-12, pp. : 1626-1627

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I trial of sorafenib in combination with ifosfamide in patients with advanced sarcoma: a Spanish group for research on sarcomas (GEIS) study

By Martín-Liberal J.   López-Pousa A.   Broto J.   Cubedo R.   Gallego O.   Brendel E.   Tirado O.   Muro X.  

Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. : 287-294

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of sorafenib in a subset of patients with advanced soft tissue sarcoma from a Phase II randomized discontinuation trial

By Pacey Simon  

Investigational New Drugs, Vol. 29, Iss. 3, 2011-06 ,pp. : 481-488

Springer Publishing Company

Access to resources Recommend Favorite

Phase II Study of Interferon Gamma in Malignant Carcinoid Tumors (E9292): A Trial of the Eastern Cooperative Oncology Group

By Stuart Keith   Levy Donna E.   Anderson Tom   Axiotis Constantine A.   Dutcher Janice P.   Eisenberg Andrew   Erban John K.   Benson III Al Bowen  

Investigational New Drugs, Vol. 22, Iss. 1, 2004-01 ,pp. : 75-81

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of sorafenib in combination with bicalutamide in patients with chemotherapy-naive castration resistant prostate cancer

By Beardsley Emma  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1652-1659

Springer Publishing Company

Access to resources Recommend Favorite

SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma

By El-Khoueiry Anthony  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1646-1651

Springer Publishing Company

Access to resources Recommend Favorite